Amphastar Pharmaceuticals (NASDAQ: AMPH) is set to announce its financial results for the third quarter of 2024 on Wednesday 6th November 2024. This highly anticipated announcement is scheduled to take place after market close. Investors will have the opportunity to learn more about the company's performance during the quarter.
According to the forecasts of financial experts on Wall Street, the concern is expected to reveal an anticipated $1.00 profit per share for the quarter. Additionally, the firm is poised to disclose a quarterly revenue of $194.74 million.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share income of $1.15. This figure was a result of the company's total revenue, which reached an impressive $180.56 million during that specific period.
The forecasts for the company's annual performance have been disclosed by Wall Street analysts, with an estimated total revenue of $746.96 million. In addition, they anticipate the company to report profit of $3.98 per share for the fiscal year.
The business has scheduled a conference call on 6th November 2024 at 05:00 PM eastern time to discuss Q3 financial results.
During Friday's trading, Amphastar Pharmaceuticals (AMPH) shares reached a low of $50.25 and a high of $51.23, along with a total volume of 172.60 thousand shares. The stock ended the regular trading session at $50.73, indicating an increase of 0.40 percent.
